Drug Approval | March 29, 2022
Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.
The facility will manufacture its Herceptin biosimilar, Tuznue
In the interim, Deepak Khanna will lead Human Health International.
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Subscribe To Our Newsletter & Stay Updated
